Literature DB >> 32627284

Assessing the impact of excluded attributes on choice in a discrete choice experiment using a follow-up question.

Carol Mansfield1, Jessie Sutphin1, Marco Boeri2.   

Abstract

Health researchers design discrete choice experiments (DCEs) to elicit preferences over attributes that define treatments. A DCE can accommodate a limited number of attributes selected by researchers based on numerous factors (e.g., respondent comprehension, cognitive burden, and sample size). For situations where researchers want information about the possible impact of an attribute excluded from the DCE, we propose a method to use a question after the DCE. This follow-up question includes the attributes in the DCE with fixed levels and an additional attribute originally excluded from the DCE. The DCE data can be used to predict the probability that respondents would select one treatment profile over another without the additional attribute. Comparing the prediction to the percentage of the sample who selected each profile when it includes the additional attribute provides information on the potential impact of the additional attribute. We provide an example using data from a DCE on treatments for chronic lymphocytic leukemia. Cost was excluded from the DCE, but the survey included a follow-up question with two fixed treatment profiles, similar to two treatments currently on the market, and a cost for each. Preferences were sensitive to modest changes in cost, highlighting the importance of gathering this information.
© 2020 John Wiley & Sons, Ltd.

Entities:  

Keywords:  discrete choice experiment; individual attribute estimates; preference analysis; share prediction

Mesh:

Year:  2020        PMID: 32627284     DOI: 10.1002/hec.4124

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  2 in total

1.  A General Public Study on Preferences and Welfare Impacts of Antimicrobial Resistance in the United Kingdom.

Authors:  Maria Veronica Dorgali; Alberto Longo; Caroline Vass; Gemma Shields; Roger Harrison; Riccardo Scarpa; Marco Boeri
Journal:  Pharmacoeconomics       Date:  2021-08-30       Impact factor: 4.558

2.  What Are the Attributes Prioritized in the Choice of Therapy in Chronic Lymphocytic Leukemia? A Patient-physician Cross-matching Analysis of a Discrete Choice Experiment.

Authors:  Luca Laurenti; Gianluca Gaidano; Francesca Romana Mauro; Stefano Molica; Patrizio Pasqualetti; Lydia Scarfò; Paolo Ghia
Journal:  Hemasphere       Date:  2022-08-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.